Preparation of meglumine antimonate loaded albumin nanoparticles and evaluation of its anti-leishmanial activity: an in vitro assay

被引:7
作者
Barazesh A. [1 ,4 ]
Motazedian M.H. [1 ]
Sattarahmady N. [2 ]
Morowvat M.H. [3 ]
Rashidi S. [1 ]
机构
[1] Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz
[2] Nanomedicine and Nanobiology Research Center, Shiraz University of Medical Sciences, Shiraz
[3] Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz
[4] Department of Microbiology and Parasitology, Faculty of Medicine, Bushehr University of Medical Sciences, Moallem Street, P. O. Box 3631, Bushehr
关键词
Albumin; Anti-leishmanial activity; Encapsulation; Glutaraldehyde; Meglumine antimonate;
D O I
10.1007/s12639-018-1018-7
中图分类号
学科分类号
摘要
Cutaneous leishmaniasis is still a health problem worldwide, especially in tropical and subtropical areas. Currently, pentavalent antimony compounds are used to treat leishmaniasis. These compounds cause various side effects in the body. Therefore, there is a need to discover new drugs with less toxicity and more therapeutic effects. In this study, we encapsulated the meglumine antimonate into the albumin as a drug carrier and evaluated the anti-leishmanial effect of the prepared nanoparticles. The precipitation method was used for this purpose by applying different concentrations of glutaraldehyde and N-(3-Dimethylaminopropyl)-N-ethyl carbodiimide hydro chloride Ethyl (DEC) and then, field emission test was performed using Scanning Electron Microscopy for evaluating the morphology and size particles. The cytotoxicity and inhibitory of drugs were evaluated on J774 macrophages and Leishmania major promastigotes, respectively. Nanodrugs prepared using glutaraldehyde (10 μl/ml) and DEC (13 mg/ml) had the smallest and largest size, respectively. The highest anti-leishmanial activity was observed in the drugs prepared with glutaraldehyde (10 μl/ml). Also this nanodrug had the lowest cytotoxicity against macrophages. Given that meglumine antimonate loaded albumin nanoparticles prepared with glutaraldehyde (10 μg/ml), can improve the anti-leishmanial effects of this old drug, it can be a good option as a drug delivery system. © 2018, Indian Society for Parasitology.
引用
收藏
页码:416 / 422
页数:6
相关论文
共 35 条
[1]  
Ahsan F., Rivas I.P., Khan M.A., Torres Suarez A.I., Targeting to macrophages: role of physicochemical properties of particulate carriers—liposomes and microspheres—on the phagocytosis by macrophages, J Control Release, 79, pp. 29-40, (2002)
[2]  
Benita S., Microencapsulation methods and industrial applications, (2006)
[3]  
Borborema S.E., Schwendener R.A., Osso J.A., de Andrade H.F., do Nascimento N., Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages, Int J Antimicrob Agents, 38, pp. 341-347, (2011)
[4]  
Chowdhary S.J., Chowdhary A., Kashaw S., Macrophage targeting: a strategy for leishmaniasis specific delivery, Int J Pharm Pharm Sci, 8, pp. 16-26, (2016)
[5]  
Dandagi P.M., Mastiholimath V.S., Patil M.B., Gupta M.K., Biodegradable microparticulate system of captopril, Int J Pharm, 307, pp. 83-88, (2006)
[6]  
Das S., Khan W., Mohsin S., Kumar N., Miltefosine loaded albumin microparticles for treatment of visceral leishmaniasis: formulation development and in vitro evaluation, Polym Adv Technol, 22, pp. 172-179, (2011)
[7]  
Date A.A., Joshi M.D., Patravale V.B., Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles, Adv Drug Deliv Rev, 59, pp. 505-521, (2007)
[8]  
Desjeux P., Human leishmaniases: epidemiology and public health aspects, World Health Stat Q, 45, pp. 267-275, (1992)
[9]  
Elzoghby A.O., Samy W.M., Elgindy N.A., Albumin-based nanoparticles as potential controlled release drug delivery systems, J Control Release, 157, pp. 168-182, (2012)
[10]  
Fouladvand M., Barazesh A., Farokhzad F., Malekizadeh H., Sartavi K., Evaluation of invitro anti-leishmanial activity of some brown, green and red algae from the Persian Gulf, Eur Rev Med Pharmacol Sci, 15, pp. 597-600, (2011)